All News about Daiichi Sankyo Ltd ADRVia Benzinga
Exposures
Product Safety
Via Benzinga
Exposures
Product Safety
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
Via Benzinga
Via Benzinga
This Cancer Focused Stock Has 60% Potential Upside, Bullish Analyst Says
September 12, 2022
Via Benzinga
Via Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|